PB2131: MAGNETISMM-7: AN OPEN-LABEL, MULTICENTER, RANDOMIZED PHASE 3 STUDY OF ELRANATAMAB VERSUS LENALIDOMIDE IN POST-TRANSPLANT PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA

ABSTRACT:

SUBMITTER: Manteca M 

PROVIDER: S-EPMC10429456 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature